Search filters

List of works by Anna Jonášová

5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity.

scientific article

A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes.

scientific article

Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment.

scientific article

Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice

scientific article published on 14 October 2013

Changes associated with lenalidomide treatment in the gene expression profiles of patients with del(5q).

scientific article published on 18 May 2012

Characterization of chromosome 11 breakpoints and the areas of deletion and amplification in patients with newly diagnosed acute myeloid leukemia.

scientific article published on 12 April 2013

Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.

scientific article published on 24 January 2016

Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow

scientific article published on 01 February 1998

DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population

scientific article published on 22 January 2013

Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome

scientific article published on 10 January 2009

Deletion of the long arm but not the 5q31 region of chromosome 5 in myeloid malignancies

scientific article published on 06 December 2011

Differential expression of homologous recombination DNA repair genes in the early and advanced stages of myelodysplastic syndrome.

scientific article published on 5 July 2017

Dynamic alterations of bone marrow cytokine landscape of myelodysplastic syndromes patients treated with 5-azacytidine.

scientific article published on 13 May 2016

Effect of erythropoietin on hepcidin expression in hemojuvelin-mutant mice

scientific article published on 12 March 2010

Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome

scientific article published on 01 January 2011

Epigenetic control of SPI1 gene by CTCF and ISWI ATPase SMARCA5.

scientific article published on 3 February 2014

Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation.

scientific article published on 6 September 2011

Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide.

scientific article published on 11 November 2014

High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide

scientific article published on 31 October 2014

Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis

scientific article published on 03 February 2014

Lenalidomide treatment induced the normalization of marker protein levels in blood plasma of patients with 5q-myelodysplastic syndrome

scientific article

Molecular cytogenetic analysis of dicentric chromosomes in acute myeloid leukemia.

scientific article published on 8 January 2016

NQO1*2 polymorphism predicts overall survival in MDS patients.

scientific article

Nature of frequent deletions in CEBPA.

scientific article published on 3 August 2009

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes

scientific article

Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents

scientific article

Recurrent chromosomal breakpoints in patients with myelodysplastic syndromes and complex karyotype versus fragile sites.

scientific article published on 3 March 2012

TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes

scientific article published on 06 May 2016

The translocation t(2;11)(p21;q23) without MLL gene rearrangement--a possible marker of good prognosis in myelodysplastic syndrome patients.

scientific article

Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q− MDS (IPSS low and intermediate-1)

scientific article published on 03 September 2012

Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond-Blackfan anemia.

scientific article

Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms

scientific article published on 14 July 2016

Paulina is supported by:

About Paulina

Help